NEUROLOGICAL DISORDER
Clinical trials for NEUROLOGICAL DISORDER explained in plain language.
Never miss a new study
Get alerted when new NEUROLOGICAL DISORDER trials appear
Sign up with your email to follow new studies for NEUROLOGICAL DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Light helmet shows promise for autism and epilepsy symptoms
Symptom relief CompletedThis study tested a special light helmet (called tPBM) on 6 autistic children aged 4–12 who also had abnormal brain activity or epilepsy. The helmet delivered near-infrared light to specific brain areas twice a week for 10 weeks. The goal was to see if it could safely improve foc…
Matched conditions: NEUROLOGICAL DISORDER
Phase: PHASE2 • Sponsor: Richard Frye • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Study pits two MG drugs Head-to-Head in everyday practice
Knowledge-focused CompletedThis study looked at how well two drugs, azathioprine and mycophenolate mofetil, work for people with myasthenia gravis in everyday medical practice. Researchers followed 82 adults with autoimmune MG for 2-3 years, measuring quality of life and side effects. The goal was to provi…
Matched conditions: NEUROLOGICAL DISORDER
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Healthy volunteers test new compound for brain disorders
Knowledge-focused CompletedThis early-stage study tested the safety of a compound called glyceryl tribenzoate (GTB) in 40 healthy adults aged 18 to 50. Participants received either a single or multiple doses of GTB or a placebo. The goal was to check for side effects and how the body processes the drug, no…
Matched conditions: NEUROLOGICAL DISORDER
Phase: PHASE1 • Sponsor: Forest Hills Lab • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC